The Kidney Awareness Registry and Education (KARE) study: protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease

Table 1 Kidney Awareness Registry and Education (KARE) study variables and outcomes

KARE Study data collection	Method of ascertainment	Baseline	Mid-point	Study end
Primary care providers
Demographic data
Age, gender, years of experience, language	Survey	+
Behavioral data
Awareness/ability to identify CKD	questionnaire [35]	+		+
Self-efficacy towards CKD management	questionnaire	+		+
Comfort communicating with patients about CKD	Communication Assessment Tool [36]	+		+
Prescription of ACEi or ARB, albuminuria quantification, nephrology referral	Medical record	+		+
Patients
Demographic data
Age, gender, race/ethnicity, social support, income, education, zip code, preferred language, insurance status	Survey	+
Food insecurity, health literacy	Screening questions	+
Clinical data
BP, Height, Weight, UACR,	Measured by study team	+		+
eGFR, metabolic bone disease parameters, glycosylated hemoglobin	Medical record	+		+
Co-morbid conditions	Medical record	+		+
Referrals, emergency department visits, hospitalizations	Medical record	+		+
Current medications	Medical record and study team	+	+	+
Quality of life, functional status	SF-12 instrument [37]	+		+
Behavioral data
CKD awareness	Survey	+	+	+
Participation in healthy behaviors	BRFSS questionnaire [40]	+	+	+
Self-efficacy for self-management	Stanford self-efficacy tool [39]	+	+	+
Medication Adherence	Morisky Medication Adherence Scale [38]	+	+	+
Communication with providers	Lorig Communication tool [39]	+	+	+

CKD chronic kidney disease, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, UACR urine albumin:creaitnine ratio, eGFR estimated glomerular filtration rate, QOL quality of life, BRFSS Behavioral Risk Factor Surveillance System

ISSN: 1471-2369